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Regular Article
HEMATOPOIESIS AND STEM CELLS
Mouse extraembryonic arterial vessels harbor precursors capable of
maturing into deﬁnitive HSCs
Sabrina Gordon-Keylock,1 Malgorzata Sobiesiak,1 Stanislav Rybtsov,1 Kate Moore,1,2 and Alexander Medvinsky1
1Institute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, Scotland, United
Kingdom; and 2Centre for Tumour Biology, Barts Cancer Institute, a Cancer Research UK Centre of Excellence, Queen Mary, University of London, John
Vane Science Centre, London, United Kingdom
Key Points
• Mouse umbilical arteries and
VAs contain precursors that
can mature into adult HSCs in
the presence of interleukin 3.
During mouse development, definitive hematopoietic stem cells (dHSCs) emerge by late
E10.5 to E11 in several hematopoietic sites. Of them, the aorta-gonad-mesonephros
(AGM) region drew particular attention owing to its capacity to autonomously initiate and
expand dHSCs in culture, indicating its key role in HSC development. The dorsal aorta
contains characteristic hematopoietic clusters and is the initial site of dHSC emergence,
where they mature through vascular endothelial (VE)-cadherin1CD45–CD41low (type 1
pre-HSCs) and VE-cadherin1CD451 (type 2 pre-HSCs) intermediates. Although dHSCs
were also found in other embryonic niches (placenta, yolk sac, and extraembryonic vessels), attempts to detect their HSC initiating
potential have been unsuccessful to date. Extraembryonic arterial vessels contain hematopoietic clusters, suggesting that they
developHSCs, but functional evidence for this has been lacking. Herewe show that umbilical cord and vitelline arteries (VAs), but not
veins, contain pre-HSCs capable ofmaturing into dHSCs in the presence of exogenous interleukin 3, although in fewer numbers than
the AGM region, and that pre-HSC activity in VAs increases with proximity to the embryo proper. Our functional data strongly
suggest that extraembryonic arteries can actively contribute to adult hematopoiesis. (Blood. 2013;122(14):2338-2345)
Introduction
Duringmouse development, hematopoietic speciﬁcation occurs from
E7.5 in the yolk sac (YS), allantois, and chorion.1-3 Primitive
hematopoiesis originating in the YS provides short-lived hemato-
poietic cells and progenitors for the developing embryo.3,4 Deﬁnitive
hematopoietic stem cells (dHSCs), capable of long-termmultilineage
hematopoietic repopulation of adult recipients, emerge only by late
E10.5 to E11. The capacity of the aorta-gonad-mesonephros (AGM)
region to generate dHSCs in organotypic cultures indicated that this
site plays an important role in HSC development.5,6 Around the time
when dHSCs appear in the AGM region, HSCs can also be found in
the placenta,7-9 YS,6,10 and umbilical cord (UC)/vitelline vessels
(VVs).11 Hematopoietic potential has also been observed in cerebral
vessels.12 ByE12.5, the placenta andYS contain elevated numbers of
dHSCs, which later migrate to the fetal liver, along with those from
the AGM region, to undergo expansion before colonizing the bone
marrow prior to birth.10 Although the extraembryonic sites harbor
dHSCs and exhibit hematopoietic potential,9,13,14 previous attempts
to demonstrate by ex vivo culture that these tissues can also generate
dHSCs have been unsuccessful.8,11 The exact tissue origin of HSCs
in mouse development remains open to debate.15
The dHSCs in the AGM region are localized to the ventral domain
of the dorsal aorta,16 possiblywithin intra-aortic hematopoietic clusters
that are closely associated with the endothelial lining.17-21 It has been
reported that dHSCs emerge via an endothelial-to-hematopoietic
transition in zebra ﬁsh,22,23 mouse,13,24,25 and embrionic stem cell
models.26,27 Recently, we demonstrated that dHSCs in the AGM
region mature in a stepwise manner from precursor cells: type 1 pre-
HSCs that express vascular endothelial (VE)-cadherin1CD45–CD41low
mature into type 2 pre-HSCs that are VE-cadherin1CD451, before
becoming fully functional adult-repopulating dHSCs.28,29
In the AGM region, intra-aortic hematopoietic clusters are
thought to be associated with HSC formation.13,19,24,25,30 Indeed, at
early stages, HSC activity is associated with the aorta but not with
cardinal veins.11,16 Similar hematopoietic cell clusters observed
within arterial components of UC and VVs (omphalomesenteric) led
to the idea that HSCs develop in major arteries.11,19,20,31
Extraembyonic vessels develop through complex morphogene-
sis.32 The UC originates mainly from the allantois protruding from
the posterior part of the embryo body shortly after gastrulation. The
capacity of the allantois to generate hematopoietic cells was ﬁrst
shown in avian embryos.33,34 In themouse, Runx1 expression occurs
in the allantois prior to circulation, and its inherent hematopoietic
capacity was conﬁrmed.1,2 Intra-allantoic vessels form de novo by
E7.5, and later umbilical vasculature fuses with the paired dorsal
aorta.32,35 By E8.5, the tip of the allantois reaches the chorion and
forms the chorio-allantoic fusion, which later becomes the embryonic
part of the placenta.32 The VVs, which connect the YS and embryo
proper, undergo extensive remodeling between E8.5 and E10.5,36
whereby the vitelline artery (VA) is fused to the dorsal aorta and the
paired vitelline veins connect to the fetal liver.37 By late E10.5 to
E11.5, the extraembryonic vessels contain some dHSCs,11 but it
remains unclear which of these vessels harbored HSCs and whether
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these HSCs migrate from the AGM region or are independently
generated in these vessels.
By using a quantitative limiting dilution approach, we demon-
strate here that UC and VV contain low numbers of dHSCs, with not
every vessel possessing HSC activity. After culture with exogenous
growth factors (GFs), signiﬁcant expansion of HSC numbers occurs
in every explant, thus revealing the presence of pre-HSCs. Using
a culture method that potently supports maturation of AGM-derived
pre-HSCs, sorting experiments showed that, similar to the AGM
region, UC and VV contain pre-HSCs.28 Subdissection of UC and
VV followed by long-term transplantation experiments showed that
pre-HSCs and dHSCs are localized exclusively to arterial but not
venous vessels.
Interleukin 3 (IL-3) has been implicated in dHSC development in
the AGM region.38 In contrast to the AGM region, UC and VV do
not express detectable levels of IL-3, and dHSC production by vessel
explants entirely depends on supplementation with exogenous IL-3,
suggesting that UC- and VV-derived HSCs may have to relocate to
the AGM region, placenta, or fetal liver to undergo further ma-
turation and expansion.
Materials and methods
Mice and embryo manipulation
Embryos were obtained from C57BL/6 (CD45.2/2) mice. E11.0 to E11.5
embryos had 41 to 47 somite pairs, withmorphologic characteristics described
by Taylor et al.39 Independent experiments performed using different em-
bryonic litters were repeated several times, as indicated. Mice were bred and
used in experiments under UK Home Ofﬁce regulations with approval of the
University of Edinburgh Ethical Review Committee. Dissections were
performed as described in the text and in Rybtsov et al28 and Taoudi et al.40
Embryonic tissueswere dissected in 7% fetal calf serum in phosphate-buffered
saline 1 MgCl2 1 CaCl2 (Gibco) with penicillin/streptomycin. Peripheral
blood (PBL) was collected either by draining the embryo after severing the
head or by gently ﬂushing the dorsal aorta using a glass pipette.
Explant and reaggregate cultures
Sorted embryo-derived cells (1 embryo equivalent [e.e.]) and 105 OP9 stromal
cells were coaggregated by centrifugation in the yellow pipette tip as described
previously.28 Explants or cell aggregates were placed onto 0.65- or 0.8-mm
membranes (Millipore), ﬂoating on Iscove modiﬁed Dulbecco medium
(Invitrogen) supplemented with L-glutamine (4 mM), penicillin/streptomycin
(50U/mL), batch-tested fetal calf serum (20%), andGFs (Peprotech: 100 ng/mL
IL-3, 100 ng/mL stem cell factor [SCF], 100 ng/mL fms-like tyrosine kinase 3
[Flt3] ligand), unless otherwise indicated. In IL-3–only conditions, 200 ng/mL
was used. Explants or coaggregates were cultured at the air-liquid interface
for 4 to 5 days (37°C, 5% CO2).
16,28 Cultures were dissociated using
dispase/collagenase solution of 1 mg/mL (Roche) for 40 minutes (37°C),
and single-cell suspensions prepared.
Repopulation assays
Donor cells from C57BL/6 (CD45.2/2) embryos were injected into C57BL/6
(CD45.1/1 or CD45.1/2) irradiated adult recipient mice (.6 weeks old),
coinjected with 50 000 carrier bone marrow cells (CD45.1/2 or CD45.1/1,
respectively) to provide short-term radioprotection. Recipient mice were
g-irradiated with a split dose of 1150 rad with an interval of 3 hours and
transplanted on the same day. Donor cell doses are denoted as embryo
equivalents, which refers to the proportion of cells relative to the number of
those cells in the original tissue. Levels of donor cell contribution were assessed
in PBL of recipients 12 to 14 weeks posttransplantation. PBLwas collected into
5 mM EDTA/phosphate-buffered saline from the tail vein by venesection and
depleted of erythrocytes (PharmLyse; BD Biosciences), before staining with
monoclonal antibodies: anti-CD16/32 (Fc-block), anti-CD45.1-antigen-
presenting cell (APC) (clone A20), anti-CD45.2-phycoerythrin (PE) (clone
104), or control isotype antibodies (eBioscience). ELDA software was used to
calculate HSC numbers in limiting dilution analyses.41 Mice exhibiting .5%
donor chimerism (.14 weeks) were considered to be repopulated with HSCs.
Multilineage ﬂow cytometric analysis was performed on PBL, thymus, bone
marrow, and spleen using monoclonal antibodies against Ter119, Mac1,
Gr1, CD3e, CD4, B220, or CD8 (BDBiosciences), conjugated with ﬂuorescein
isothiocyanate, PE, APC, or biotin, which was detected by secondary
staining with streptavidin-PE or streptavidin-APC.
Flow cytometry
Flow cytometry was performed on Fortessa or FACSCaliburs. Sorting was
performed on FACSAriaII orMoFlo (Cytomation), using FACSDiva software.
Data were analyzed in FlowJo software (TreeStar). Single-cell suspensions
were prepared by dispase/collagenase-mediated dissociation and stained with
anti-CD45-PE or CD45-A488 (clone 30-F11) and VE-cadherin (clone
11.D4.1) (BD Biosciences), conjugated in-house to biotin and detected by
secondary streptavidin-APC, or VE-cadherin clone BV13 conjugated to A647
(Biolegend). The 7-aminoactinomycin D viability staining solution was
used to exclude dead cells, and gates were set using appropriate isotype
antibodies and ﬂuorescence minus 1 controls. Purity of sorted cells was
checked before culture.
Hematopoietic colony assays
Hematopoietic progenitors were quantiﬁed in clonogenic colony forming unit
(CFU) cell assays. Cells were seeded into methylcellulose supplemented with
several cytokines (M3434; StemCell Technologies) that stimulate progenitors
to differentiate into mature hematopoietic cell types. Colonies were counted
after 8 to 10 days of incubation at 37°C and categorized based on hema-
topoietic cell content.
Microscopy
Photographs were taken on a LeicaMZFLIII microscope using a Hamamatsu
digital camera and processed in Volocity software or Adobe Photoshop.
Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR)
RNA was isolated from embryonic tissues (using 5-10 e.e. of tissue for each
sample) with Qiagen RNeasy mini kit (1DNAse treatment) and single-strand
complementary (cDNA) prepared using SuperScriptVILO cDNA Synthesis
(Invitrogen) andQiaquick puriﬁcation kits (Qiagen). A universal probe library
(UPL) strategy with Lightcycler 480 probes mastermix kit and machine
(Roche) were used for qRT-PCR. Triplicate reactions were set up with 20 to
60 ng cDNA each. Tissue samples from 4 independent embryo litters were
assessed. Gene expression levels were determined relative to the TBP
housekeeping gene. Primers included the following: SCF (UPL probe 68)
59 primer, agcgctgcctttccttatg, and 39 primer, ccttggttttgacaagaggatt; Flt3L
(UPL probe 25) 59 primer, aggcctgccagaatttctct, and 39 primer, tctagggctatgg
gactcctt; IL-3 (UPL probe 94) 59 primer, tacatctgcgaatgactctgc, and 39 primer,
ggctgaggtggtctagaggtt; and TBP (UPL probe 97 or 11) 59 primer, ggggagctg
tgatgtgaagt, and 39 primer, ccaggaaataattctggctca.
Results
UCs and VVs contain VE-cad1CD451 dHSCs
To determine the surface phenotype of dHSCs in extraembryonic
vessels, cell suspensions were prepared from E11.5 UCs and VVs,
and cells were sorted by ﬂuorescence-activated cell sorter based on
VE-cadherin and CD45 expression. Four cell populations were
transplanted directly, without a culture step, into irradiated adult
recipients (Figure 1A-B). Recipient PBL was assessed for donor cell
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contribution 13 to 14 weeks posttransplantation. In 6 independent
sorting experiments, long-term deﬁnitive HSC activity resided only
within the VE-cad1CD451 fraction of extraembryonic vessels,
similar to the AGM region.30,40 Because only 5 out of 12 recipients
were repopulated, each of them likely received only 1 dHSC. Bone
marrow from 2 primary recipients was harvested and injected sep-
arately into 3 secondary recipients, all of which showed high levels of
donor-derived hematopoietic repopulation (supplemental Figure 1A,
available on the Blood Web site).
In order to assess the numbers of dHSCs present, E11.5 UC and
VV were individually dissociated and injected without sorting into
irradiated mice at doses of 1 or 3 e.e. per recipient. Only 5 out of 18
recipients that received in total 30 UCs showed donor-derived
repopulation (Figure 2A), indicating a frequency of ;0.17 dHSC
Figure 1. Definitive HSCs in E11.5 UC and VV are
enriched in the VE-cad1CD451 fraction. (A) UC and VV
were pooled and sorted on the basis of VE-cadherin and
CD45 expression. (B) Four sorted cell populations were
transplanted directly into irradiated adult recipients (8 e.e.
per mouse), and the level of donor-derived engraftment in
PBL was assessed 13 to 14 weeks posttransplantation
(n 5 6 independent experiments).
Figure 2. Pre-HSC potential is revealed in explant
cultures of UC and VV. (A-B) Direct transplants. E11.5
UC or VV were separated on dissection and transplanted
individually into irradiated recipients, and the level of
donor-derived PBL chimerism (%) was determined 14
weeks posttransplantation. Only 5 out of 30 UCs trans-
planted into recipients and 5 out of 22 VV recipients were
repopulated. (C-D) Transplantation of explant cultures.
UC or VV explants were cultured for 4 days with GF
(IL-3 1 SCF 1 Flt3l) and transplanted separately into
irradiated mice as follows: 1 UC explant per 2 recipients
(8 explants in total) and 0.2 to 0.5 VV explants per 1
recipient. Note that after culture all UC and VV explants
contained HSC activity. M, recipient mouse.
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per UC. Similarly, only 5 out of 22 mice were repopulated when
a total of 22 VVs were injected (Figure 2B), indicating a frequency
of ;0.23 HSC per VV. Thus, both UC and VV appear to harbor
fewer dHSCs than the AGM region, which reportedly contains 0.3
to 1.0 dHSC per AGM, depending on the exact stage.10,39
UCs and VVs can initiate dHSCs in explant culture
supplemented with exogenous GFs
Unlike dHSCs, their precursors (pre-HSCs) are not yet able to re-
populate the blood system of irradiated adult recipients. Therefore, to
detect pre-HSCs in embryonic tissues, a culture step (organ or ag-
gregate) was introduced in which they can mature into dHSCs.5,16,29
Using this approach, we determined whether extraembryonic vessels
could initiate dHSCs in culture (Figures 2 and 3; supplemental
Figure 2). Isolated UC explants were cultured in the presence of
GFs (IL-31 SCF1 Flt3L) for 4 days. Transplantation of individual
UC explants into 2 irradiated recipients each resulted in hematopoi-
etic repopulation of at least 1 recipient (Figure 2C). Although there
was ,0.2 dHSC per fresh UC, after culture UCs contained at least
1.5 dHSCs per explant (Figure 2C). Notably, not every fresh UC
contained dHSCs, but each developed HSC activity during culture,
indicating that every vessel contained pre-HSCs.
dHSC generation was also observed in VV explants accurately
separated from YS at the point of entry. Although only ;0.23
dHSC per VV was detected in freshly isolated VV, cultured VVs
generated on average 2.6 dHSCs per VV (Figure 2D). By contrast,
injection of YS explants carefully dissected from VVs did not lead
to any repopulation (Figure 2D). dHSCs from both UC and VV
explants successfully achieved multilineage repopulation of sec-
ondary recipients (supplemental Figures 1B-C, 3, and 4).
Limiting dilution analyses revealed that cultured explants ex-
hibited extensive generation of dHSCs (Figure 4A). A frequency of
9.6 dHSCs per UC was observed (calculated by ELDA software, see
Materials and methods), representing an expansion of 56-fold
compared with fresh tissues. Cultured VV in the presence of GFs
also showed signiﬁcant expansion of dHSCs (Figure 4B). In the
absence of GFs, dHSCs were only maintained in UC and VV
explants (compare Figure 2A-B and Figure 4A-B), in contrast to the
AGM region, which can initiate and expand HSCs self-
autonomously by;10-fold.5 IL-3 or a combination of SCF, Flt3L,
and IL-3 can substantially stimulate HSC maturation in the AGM
region.29,38 Q-PCR analysis showed that the AGM region expresses
all 3 of these GFs, although the IL-3 message was only detectable in
5 out of 8 preparations (each obtained from up to 10 AGM regions)
(Figure 4D) and was on occasion detectable in placenta or fetal liver
(supplemental Figure 5). By contrast, SCF and Flt3L, but not IL-3,
were detected in freshly isolated UC and VV, which could explain
why UC and VV explants failed to enhance dHSC activity in the
absence of exogenous IL-3. Supplementation with IL-3 alone
signiﬁcantly stimulated dHSC generation in VV and UC explants by
at least eightfold and 25-fold, respectively (Figure 4A-B).
Hematopoietic progenitors (CFU-C) as well as CD451 cells in
UC and VV also signiﬁcantly increased in numbers after culture with
Figure 3. Dissection of extraembryonic vessels. (A)
E11.5 wild-type embryo, showing position of VV and UC.
(B) Dissection of UC. Separation of artery and vein is
shown. (C) Dissection of VV. YS and midgut loop were
removed. White dotted lines indicate points of dissection
to isolate vessels. Original magnification38 (A),340 (B),
and 332 (C). CD, chorion disk; D, distal; Em, embryo
proper; FL, fetal liver; P, proximal; PL, placenta.
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exogenous GFs, but to a lesser extent than in the AGM region, and
they were variable (Figure 4C; supplemental Figure 6), possibly due
to variations in blood contents between individual embryos.39
Phenotypic characterization of pre-HSCs in
extraembryonic vessels
To determine the phenotype of pre-HSCs in extraembryonic vessels,
cell suspensions fromUC andVVwere sorted based on VE-cadherin
and CD45 expression. Isolated cell fractions were coaggregated with
OP9 stroma and cultured for 4 days in conditions known to promote
maturation of AGM region pre-HSCs.28,29 Both VE-cad1CD451
and VE-cad1CD45– cell fractions from UC and VV gave rise to
dHSCs after culture (Figure 5A). Thus, similar to the AGM region,
UC and VV contain immature VE-cad1CD45– type 1 pre-HSCs
that are distinct from dHSCs (VE-cad1CD451) (Figure 1).
VE-cad1CD451 type 2 pre-HSCs could not be distinguished from
dHSCs in these experiments.
Notably, cells with pre-HSC type 1 phenotype sorted from the
chorion disk, YS proper, and PBL coaggregated with OP9 cells did
not give rise to dHSCs (Figure 5B and supplemental Figure 7). Thus,
type 1 pre-HSCs are not detectable in PBL at this stage but appear to
be localized within the AGM region and extraembryonic vessels.
Pre-HSC activity is associated with extraembryonic arteries
but not veins
Initially, HSC activity in theAGM region correlates with the aorta, but
not the cardinal veins.11,16 It was therefore of interest to test whether
pre-HSCs are associated exclusively with extraembryonic arteries.
UC and VV arteries and veins were subdissected and cultured sep-
arately for 4 days before transplantation into irradiated recipients
(Figure 6). Umbilical arteries were distinguished from veins by the
characteristic arterial bifurcation proximal to the embryo (Figure 3B).
VAs and vitelline veins of the YS were distinguished by their con-
nection to the dorsal aorta and fetal liver, respectively (Figure 3C).
In all 5 independent experiments, dHSC activity was mostly
associated with extraembryonic arteries, but not veins. In 1 recipient,
repopulation occurred from a cultured umbilical vein, which might
arise from incomplete separation from a closely adjacent artery.
Although venous explants contained CD451 cells, CFU-C potential
in veins was rare and variable (supplemental Figure 6).
Pre-HSC activity increases with proximity to the embryo proper
To examine the distribution of pre-HSC activity within the VA,
vessels were subdissected into 4 portions (Figure 7A) and cultured
Figure 4. Expansion of HSC and progenitor numbers in the presence of GFs. (A) In the absence of GFs, HSCs are only maintained in UC explants but show 56-fold
increase with GFs (IL-31 SCF1 Flt3L). Addition of IL-3 alone was found to be sufficient to support HSC expansion; 0.05 to 1 e.e. was injected per recipient, as indicated, and
engraftment was assessed 12 to 14 weeks posttransplantation in PBL. (B) VV or YSs were cultured for 4 days in the presence of the 3 GFs, with IL-3 only, or without GFs and
injected into irradiated recipients (at 0.5 VV per mouse and 1 YS per mouse). Engraftment was assessed 12 to 14 weeks posttransplantation in PBL (n 5 5 independent
experiments). (C) CFU-C progenitor numbers increase after 4 days of explant culture in the presence of 3 GFs (n 5 2-5 independent experiments). Values refer to fold
increase in CFU-C in explants compared with their uncultured counterparts. (D) Levels of IL-3, SCF, and Flt3l expression were assessed by qRT-PCR relative to expression of
the TBP housekeeping gene (n 5 3-8 independent RNA preparations, representing up to 10 pooled tissues each).
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separately before transplantation into irradiated adult recipients.
Pre-HSC activity appeared to gradually increase in a distal-to-
proximal direction, with more HSCs being generated closer to the
embryo proper (Figure 7B). Interestingly, when entire VV explants
included the midgut region that is associated with portion 4, as
shown in Figure 7A, dHSC activity emerged even in the absence of
GFs (supplemental Figure 8). No dHSC activity was detected in YS
explants, in accordance with our previous explant and reaggregation
experiments (Figures 4B and 5B).28 Distribution of pre-HSC activity
in UC arteries was not assessed.
Discussion
In the developing mouse embryo, the ﬁrst dHSCs are detected in the
AGM region by late E10 to E11. Organ culture and sorting ex-
periments demonstrated that this tissue is able to initiate and support
stepwise maturation of dHSCs from resident precursors.5,28,29 The
placenta, YS, and UC/ VV also contain dHSCs,7,8,10,11 but it remains
unclear whether they arise here de novo. Using a quantitative
approach, we show that dHSCs are present at low frequencies in
fresh E11.5 UC and VV and that, similar to the AGM region, they
are enriched in the VE-cad1CD451 fraction.40
The observation that umbilical arteries and VAs contain hema-
topoietic clusters11,19-21,42 has been broadly considered an indi-
cation of HSC development. Our data show that pre-HSCs exist in
extraembryonic vessels and that explants in the presence of exogenous
GFs are able to induce expansion of dHSCs, although to a lesser extent
than the AGM region (;50-fold compared with 150-fold, respec-
tively).29 Sorting experiments revealed that UCandVVcontain type 1
pre-HSCs (VE-cad1CD45–). Although these experiments did not
allow direct detection of type 2 pre-HSCs, because of their phenotypic
similarity to VE-cad1CD451 dHSCs, it is reasonable to assume that
dHSC maturation occurs through this intermediate, as in the AGM
region.28 HSC activity was not detected after culture of sorted VE-
cad1CD45– YS cells or in YS explants except for 1 low repopulated
mouse, in contrast to previous report.38 This might be due to differ-
ences in culture methods or inadvertent inclusion of small fragments
of extraembryonic vessels in the YS explants. Interestingly, we were
not able to detect type 1 pre-HSCs (VE-cad1CD45–) in the E11.5
chorion disk or PBL, suggesting that these precursors localize to
the AGM region, UC, and VV. Because PBL did not contain pre-
HSC activity, it seems that pre-HSCs do not seed the extraembryonic
vessels through the circulation, although this possibility cannot be
fully excluded. Our previous detection of rare HSCs in circulation
(;0.1 HSC per e.e.)10 could be due to inadvertent inclusion of
fragments of extraembryonic vessels in blood preparations.
Although HSC activity is exhibited at lower levels than in the
AGM region, the extraembryonic arteries harbor large intraluminal
hematopoietic clusters. The absence of such clusters in extraem-
bryonic veins led to speculation about an exclusive role of arterial
vessels in HSC formation.11 We tested this functionally in isolated
extraembryonic arteries and veins and conﬁrmed that pre-HSC/
dHSC activity is associated only with the arteries. It is not yet clear
why HSC development is associated with arteries, but it appears
that to a certain extent, arterial and HSC speciﬁcation are deﬁned
by common signaling pathways, such as Notch signaling.43-45
Development of HSCs is enhanced in culture by several keyGFs:
SCF, Flt3L, and IL-3.29,38 The AGM region expresses all 3 of these
factors, although IL-3 was not detected in all AGM preparations,
Figure 5. Type 1 pre-HSCs are present in UC and VV. (A) Four populations sorted
based on VE-cadherin and CD45 expression were coaggregated with OP9 cells and
transplanted after 4 days of culture (with IL-3 1 SCF 1 Flt3l). The level (%) of donor
engraftment in PBL was assessed 14 weeks after transplantation (n5 7 independent
experiments). HSC activity correlated with VE-cad1CD451 and VE-cad1CD45–
fractions. (B) Type 1 pre-HSCs (VE-cad1CD45–) from different embryonic tissues
were coaggregated with OP9 cells and transplanted after 4 days of culture. Note that
VV and UC contain type 1 pre-HSCs.
Figure 6. Pre-HSC activity is associated with extraembryonic arteries, but not
veins. Arteries and veins subdissected from UC and VV were cultured separately
for 4 days with GFs (IL-3 1 SCF 1 Flt3l) and transplanted into irradiated recipients
(1 e.e. per mouse). Donor engraftment was assessed 12 to 14 weeks posttrans-
plantation (n 5 5 independent experiments).
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likely reﬂecting the rarity of IL-3–expressing cells.38 IL-3 could also
be detected in placental and fetal liver preparations. However,
in UC or VV samples, IL-3 was completely undetectable, and its
addition alone was sufﬁcient to stimulate dHSC generation. Because
extraembryonic vessels do not exhibit autonomous HSC stimu-
latory capacity (in the absence of exogenous GFs), it is conceivable
that resident pre-HSCs migrate either interstitially to the AGM
region (against blood ﬂow) or through circulation toward fetal liver
or placenta to undergo maturation/expansion through the action of
IL-3 or other factors. Exact migratory patterns of maturing HSCs
remain to be elucidated. Interestingly, pre-HSC activity in the VA
increases with proximity to the embryo proper, which could be
deﬁned by some stimulatory factors secreted by the embryo proper.46-
48 In line with this, explants of VV with associated midgut were
able to enhance dHSC activity in the absence of exogenous GFs.
We recently reported that in the human embryo the AGM
region is the ﬁrst site of HSC appearance.49 In contrast to the
mouse, the human UC at this stage contains no HSCs. It is not clear
at present which mechanisms underlie this difference between the
2 species.
In conclusion, we have shown that the extraembryonic arterial
vessels contain pre-HSCs, which are capable of maturing into de-
ﬁnitive HSCs. Whether these extraembryonic pre-HSCs emerge
in situ or emigrate from another source remains to be elucidated.
However, it is reasonable to speculate that in addition to the AGM
region, these vessels are an extra source of maturing adult HSCs.
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